(Q54954340)

English

SK-MEL-93 DX-2

cell line

SK-MEL-93-DX-2
SK-MEL-93 DX2
SK-MEL-93 (DX2)
DX-2
DX2
SK-MEL-93(2)
SK-MEL-93-2
DX-Mel-2

In more languages

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

autologous cell line

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

described by source

Induction of growth factor RNA expression in human malignant melanoma: markers of transformation

1 reference

Cellosaurus release 49

14 July 2024

Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma

1 reference

Cellosaurus release 49

14 July 2024

Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity

1 reference

Cellosaurus release 49

14 July 2024

A molecular mechanism of complement resistance of human melanoma cells

1 reference

Cellosaurus release 49

14 July 2024

Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies

1 reference

Cellosaurus release 49

14 July 2024

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

Cellosaurus release 49

14 July 2024

Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens

1 reference

Cellosaurus release 49

14 July 2024

HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines

1 reference

Cellosaurus release 49

14 July 2024

Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54954340&oldid=2204570743"